Neoadjuvant intratumoral immunotherapy with cowpea mosaic virus induces local and systemic antitumor efficacy in canine mammary cancer patients.
This study evaluated the efficacy, safety, and effects on treated and untreated tumors, and clinical impact of neoadjuvant intratumoral empty cowpea mosaic virus (eCPMV) immunotherapy in CMC patients. Overall design: Impact of neoadjuvant intratumoral empty cowpea mosaic virus immunotherapy on canine mammary cancer  gene expression profiles generated by RNA-seq and tumor size in treated and untreated patients.